Mumbai’s stock indices declined in early trading amid rising crude oil prices above $91 a barrel, renewing inflation concerns and geopolitical anxieties affecting investor sentiment, with technology shares leading the downturn and markets remaining sensitive to Middle East tensions.
Mumbai equities slipped in early trade on Tuesday as a rebound in crude oil above $91 a barrel renewed concern over inflation and imported costs, with investors again turning cautious as hopes for a US-Iran peace deal faded. The Sensex fell 365 points, or 0.47%, to 77,362, while the Nifty eased 76 points, or 0.31%, to 24,211.
Technology shares led the decline, with Nifty IT dropping more than 1%. Broader weakness was also seen in mid- and small-cap technology and telecom stocks, as well as realty. Financial services, private banks, media, metals and fast-moving consumer goods were also lower, although auto stocks and public sector banks managed modest gains.
The move echoed earlier swings in Indian markets this year, when a sharper spike in crude and escalating US-Iran tensions rattled investors. In March, HSBC said the Nifty 50 and Sensex fell hard as Brent crude jumped and volatility spiked, while live market coverage from that period showed traders bracing for further pressure on global risk assets. On April 9, however, markets staged a powerful rebound after a ceasefire eased supply fears and triggered one of the Sensex’s strongest sessions in years.
That volatility has remained closely tied to oil, geopolitics and the rupee. A May note from Union Bank of India warned that crude above $100 a barrel can feed inflation, keep central banks cautious and pressure the currency, while other market reports in recent months have shown Indian equities quickly repricing whenever the Strait of Hormuz or broader Middle East tensions threaten energy flows. For now, the latest pullback suggests investors remain highly sensitive to any renewed disruption in oil markets.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
